Author
James O. J. Davies
University of OxfordORCID 0000-0002-4108-4357Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2018-2026 · peak 4/yrCo-Author Collaboration Network
10 top collaborators · 26 mutual co-author links16 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
Menin maintains enhancer-promoter interactions in a leukemia-specific manner
Vassilena Sharlandjieva, Catherine Chahrour, Frederik Heymann Lassen…·Thomas A. Milne
The paper investigates Menin's role in enhancer-promoter interactions in MLL-rearranged and NPM1c leukemia models, finding context-dependent effects on transcriptional regulation and enhancer function.
- Molecular BiologybioRxivPreprint
FACT safeguards promoter topology by maintaining nucleosomes and restricting chromatin factor spreading
Ana M. Dopico-Fernandez, Hangpeng Li, Catherine Chahrour…·Thomas A. Milne
This study shows FACT maintains promoter topology by preserving nucleosomes and preventing chromatin factor spreading into gene bodies.
1 citation - Cancer BiologybioRxivPreprint
Genome editing for treatment of JAK2 V617F-driven myeloproliferative neoplasms
Roman M. Doll, Yuqi Shen, Zoë C. Wong…·James O. J. Davies
This study uses CRISPR-Cas genome editing to selectively inactivate JAK2 V617F mutations in patient cells, showing that heterozygous cells are not oncogene addicted while homozygous cells are eradicated, suggesting genome editing as a potential treatment for MPNs.
- Molecular BiologybioRxivPreprint
Enhancers mediate euchromatin hopping at chromatin contact points
Shanelle Mullany, Tiegh Taylor, Hangpeng Li…·Jennifer A. Mitchell
The paper shows enhancers mediate euchromatin hopping, spreading euchromatin features to distal regions through chromatin looping, redefining enhancer identification using chromatin features.
DOI 10.1101/2025.09.05.674255 - Cancer BiologyBloodPeer-reviewed
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression between patients
Alastair Smith, Nicholas Denny, Catherine Chahrour…·Thomas A. Milne
This study identifies enhancer heterogeneity as a driver of transcriptional differences in KMT2A::AFF1 ALL patients, revealing patient-specific enhancer activity at oncogenes.
- GenomicsbioRxivPreprint
Sustained MYB activity drives emergent enhancer activation and precise enhancer-promoter interactions
I‐Jun Lau, Joe R. Harman, Alastair Smith…·Thomas A. Milne
This study shows that MYB activity sustains enhancer-promoter interactions and transcription by maintaining enhancer function in leukemia.
- Cancer BiologybioRxiv
Focal Deletions of a Promoter Tether Activate the IRX3 Oncogene in T Cell Acute Lymphoblastic Leukemia
Sunniyat Rahman, Gianna Bloye, Nadine Farah…·Marc R. Mansour
The paper identifies a novel mechanism where focal deletions of an intronic element in FTO lead to IRX3 activation in T-ALL through enhancer hijacking.
DOI 10.1182/blood.2024024300 - Molecular BiologyThe EMBO JournalPeer-reviewed
Pioneer activity distinguishes activating from non-activating pluripotency transcription factor binding sites
Michela Maresca, Teun van den Brand, Hangpeng Li…·Elzo de Wit
The paper identifies that SOX2 maintains chromatin accessibility at regulatory sites that drive gene expression, distinguishing them from non-activating binding sites.
- Molecular BiologyNature CommunicationsPeer-reviewed
PAF1 and FACT cooperate with MLL-AF4 to drive enhancer activity in leukemia
Nicholas T. Crump, Alastair Smith, Laura Godfrey…·Thomas A. Milne
This study identifies PAF1 and FACT as essential for enhancer activity in MLL-AF4-driven leukemia by maintaining histone acetylation and enhancer-promoter interactions.
- GenomicsNature CommunicationsPeer-reviewed
Analysis of sub-kilobase chromatin topology reveals nano-scale regulatory interactions with variable dependence on cohesin and CTCF
Abrar Aljahani, Hua Peng, Magdalena A. Karpińska…·A. Marieke Oudelaar
The paper analyzes sub-kilobase chromatin topology to show that nano-scale regulatory interactions depend on CTCF but not cohesin, and that cohesin affects longer-range enhancer-promoter interactions.
121 citationstop 1% - Molecular BiologyNature CommunicationsPeer-reviewed
BET inhibition disrupts transcription but retains enhancer-promoter contact
Nicholas T. Crump, Erica Ballabio, Laura Godfrey…·Thomas A. Milne
The paper shows BET inhibition reduces transcription but not enhancer-promoter contacts, suggesting these processes are separable.
123 citationstop 1% - GenomicsbioRxivPreprint
Targeted high-resolution chromosome conformation capture at genome-wide scale.
Damien J. Downes, Matthew E. Gosden, Jelena M. Telenius…·Jim R. Hughes
The paper introduces a new method, NuTi Capture-C, that improves high-resolution chromosome conformation capture by reducing noise and increasing sequencing content, enabling reproducible genome-wide interaction profiles.
3 citations - BioinformaticsbioRxivPreprint
CaptureCompendium: a comprehensive toolkit for 3C analysis.
Jelena M. Telenius, Damien J. Downes, Martin J. Sergeant…·Jim R. Hughes
CaptureCompendium provides software tools to simplify the design, analysis, and visualization of 3C experiments, addressing the need for specialized bioinformatics skills in genome folding studies.
22 citations - GeneticsbioRxivPreprint
An integrated platform to systematically identify causal variants and genes for polygenic human traits.
Damien J. Downes, Ron Schweßinger, Stephanie Hill…·Jim R. Hughes
The paper develops a platform combining ATAC-seq, DNaseI footprints, NG Capture-C, and machine learning to identify causal variants and genes for polygenic human traits.
- GeneticsNature GeneticsPeer-reviewed
Single-cell chromatin interactions reveal regulatory hubs in dynamic compartmentalized domains
A. Marieke Oudelaar, James O. J. Davies, Lars L. P. Hanssen…·Jim R. Hughes
The paper develops Tri-C, a single-cell 3C method, to reveal dynamic chromatin interactions and regulatory hubs in mammalian cells.